Two studies were performed to assess the accuracy of non-invasive methods in detecting intra-abdominal metastases from breast cancer. Firstly, the sites of spread detected at the time of first presentation with metastases were compared with the sites of spread shown at necropsy in the same patients. Although about two-thirds of the patients with bone and lung metastases at necropsy had had metastases detected at these sites when they first presented with metastases, only a third of the patients with liver metastases and none of those with other intraabdominal metastases had had evidence of disease at first presentation with metastases. The second study confirmed a poor detection rate of liver and other intraabdominal metastases in patients with breast cancer undergoing laparotomy and oophorectomy who were staged immediately before operation.
Introduction
About 20°of patients with primary breast cancer develop metastases within 18 months of mastectomy and 40-50% within five years.' Some of these patients may have detectable metastases which are missed at presentation because of the inadequacy of preoperative screening procedures, particularly those for detecting intra-abdominal metastases. We therefore examined this problem, firstly, by comparing the sites of metastases detected by staging tests with subsequent necropsy findings and, secondly, by comparing the operative findings at laparotomy (for oophorectomy) with the results of preoperative staging tests.
Methods and results
Patients were investigated before primary treatment, when they first presented with metastatic disease, and at intervals thereafter. Investigations included estimation of the serum bilirubin, alkaline phosphatase, and serum alanine transferase concentrations. A gamma-camera (Pho-Gamma HPIII) was used to perform liver scanning 20 minutes after intravenous injection of 5 mCi of 99mTc sulphur colloid and bone scanning one to two hours after intravenous injection of 10 mCi of 99mTc polyphosphate or 99mTc MDP. Greyscale ultrasonography by the method described by Taylor et a13 was used to examine the liver. The bones were also examined by radiological skeletal survey, and all patients underwent chest radiography and cytological examination of bone marrow aspirate from the iliac crest.
In the first study of 33 patients who had died from breast cancer the extent of disease at necropsy was compared with the extent of disease detected in the same patients when they had first presented with metastatic disease (table I) . Bone metastases were found in 32 patients at necropsy and had been detected in 20 at the time of first presentation with metastases. Lung metastases were found in 20 patients at necropsy and in 13 at first presentation. Liver metastases, however, were found in 29 patients at necropsy but had been detected in only 11 when the patients first presented with metastases. The efficacy of the different clinical tests used is shown in table II. Excision of the lump to determine the malignancy grade, lymphoplasmocytic infiltration, and vascular invasion within the primary tumour will improve the prognostic accuracy, as will premastectomy axillary node biopsy to confirm gross disease of axillary nodes. Some or all of these factors may be combined to indicate a high likelihood of occult metastases in some patients who could be considered for staging laparotomy before primary treatment.
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References Fisher, B et al, Annals of Surgery, 1968 , 168, 337. 2Tormey, D C, Cancer, 1975 3Taylor, K J W, Carpenter, D A, and McCready, V R,3ournal of Clinical Ultrasound, 1973, 1, 284. 4Fisher, B, Carbone, P, and Economa, S G, New England Journal of Medicine, 1975 , 292, 117. aBonadonna, G, et al, New England Journal of Medicine, 1976 6 Bonadonna, G, International3Journal of Radiotherapy and Oncology, 1977, 2, 237. 7 Glees, J, et al, Lancet, 1978 , 1, 210. (Accepted 28 April 1978 Comparison of performance of various sphygmomanometers with intra-arterial blood-pressure readings S N HUNYOR, J M FLYNN, C COCHINEAS British Medical Journal, 1978, 2, 159-162 Summary and conclusions Seven types of sphygmomanometer were used in random order on each of nine hypertensive patients and the readings compared with simultaneous intra-arterial blood-pressure recordings. All the devices gave significantly different values for systolic pressure, and only two measured diastolic pressure without significant error. Systolic pressure was consistently underestimated (range 31-7 mm Hg), and all but one instrument overestimated diastolic pressure (range 10-2 mm Hg). The variability of readings was least with the standard mercury sphygmomanometer and the random-zero machine, while with some of the more automated devices single readings were in error up to -68/33 mm Hg.
The strong correlations found between intra-arterial and cuff systolic pressures with all devices tested and significant correlations for diastolic pressure with all but one device indicate that, with one possible exception, the sphygmomanometers would give accurate results where a change in blood pressure was the main concern.
Introduction Indirect measurement of blood pressure is undertaken with many more-or-less automated devices whose performance characteristics are poorly documented. In some cases the principle of their operation is not stated and it may not be clear whether they use phase IV or phase V of the Korotkoff sounds for the diastolic end-point. This second factor is highly relevant in exercise, pregnancy, and other high-output states. human observer has preserved or even increased the accuracy of the traditional sphygmomanometer. Labarthe et a14 assessed the performance characteristics of various sphygmomanometers but did not use direct readings as a basis for comparison and omitted newer, simple, and relatively cheap semiautomatic devices, some of which are aimed at selfmeasurement. Several newer devices have features such as audiovisual signalling of end-points, adjustable preset deflation rate, elimination of observer bias and error, and results in hardcopy form. Any of these features may make one or other model the instrument of choice for particular purposes, such as selfmeasurement of blood pressure, semiautomated pressure monitoring, epidemiological surveys, or assessment of antihypertensive agents, provided that a given standard of accuracy can be assumed or demonstrated.
We have tested a sample of sphygmomanometers, including the common clinical mercurial model, which varied widely in cost and the amount of training needed by users. They represented mercurial and aneroid models based on human detection of Korotkoff sounds, sound filters, and an ultrasound principle. The study was designed to correspond to everyday clinical application and we did not consider the ease of use or accuracy of the instruments in untrained hands.
Materials and methods
We used seven different types of sphygmomanometer (see table I) in random order on nine patients aged 25-80 years, while simultaneously recording direct intra-arterial blood pressure. The patients were receiving various drug regimens for hypertension and presented a range of blood pressure levels. All gave consent to the study. One patient (case 1) had frequent ventricular ectopic beats, and one other (case 9) was in controlled atrial fibrillation.
Supine blood pressure was taken as the average of two readings, phase V being used as the diastolic end-point when observer auscultation was used. In one patient (case 2) there was no disappearance of sounds down to zero, and in this case muffling (phase IV) was used for the diastolic end-point. Intra-arterial pressure was determined as the average of 15 complexes immediately preceding cuff inflation.
The blood-pressure cuff was applied to the arm containing a 50 mm 17-gauge Teflon cannula (Dwellcath, TUTA Laboratories, Lane Cove, Australia) inserted into the brachial artery. Intra-arterial blood pressure was measured by a Siemens model 746 pressure transducer and a Philips amplifier type XV 1505, direct calibration of the system being carried out on the day of the procedure. The resonant frequency of the whole system was 13 8 Hz with a damping factor of 0 37. Zero reference level was taken as midthorax in the supine position and was
